Wulf H. Utian | Academic Influence

Wulf H. Utian's AcademicInfluence.com Rankings

Wulf H. Utian

Philosophy

#10079

World Rank

#13781

Historical Rank

Logic

#7018

World Rank

#8622

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Wulf H. Utian's Degrees

Masters Medicine University of Cape Town
PhD Obstetrics and Gynecology University of Cape Town

Why Is Wulf H. Utian Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Wulf H. Utian is a physician, reproductive endocrinologist, clinical researcher, and academic women's health department administrator. He is best known for first recognizing menopause as a potential health-related issue. He is the co-founder of the International Menopause Society and founder of the North American Menopause Society. Previously he has worked as a medical department Director at the Mount Sinai Medical Center, the University Hospitals of Cleveland, and academic chairman of the department of Reproductive Biology at Case Western Reserve University School of Medicine. He is currently the Arthur H. Bill Professor Emeritus of Reproductive Biology at the Case Western Reserve University School of Medicine, a consultant in women's health, and Scientific Director Emeritus of Rapid Medical Research Inc.

(See a Problem?)

Wulf H. Utian's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Executive summary: Stages of Reproductive Aging Workshop (STRAW) (2001) (646)
Postmenopausal hormone therapy: an Endocrine Society scientific statement. (2010) (610)
The 2017 hormone therapy position statement of The North American Menopause Society (2017) (532)
Executive summary: Stages of Reproductive Aging Workshop (STRAW). (2001) (472)
Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. (2005) (449)
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society (2008) (367)
Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review (2005) (366)
Stages of Reproductive Aging Workshop (STRAW). (2001) (335)
Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. (2001) (300)
Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society (2007) (248)
Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society (2015) (247)
Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001. (2001) (241)
Sex steroids and growth factors differentially regulate the growth and differentiation of cultured human endometrial stromal cells. (1991) (232)
Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial (2009) (191)
The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause (2002) (172)
Assessment and management of women's sexual dysfunctions: problematic desire and arousal. (2005) (169)
Expression of the insulin‐like and platelet‐derived growth factor genes in human uterine tissues (1990) (164)
The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010) (2011) (148)
Effective Treatment of Vaginal Atrophy With an Ultra–Low-Dose Estradiol Vaginal Tablet (2008) (142)
Women and Menopause: Beliefs, Attitudes, and Behaviors. The North American Menopause Society 1997 Menopause Survey (1998) (132)
The International Menopause Society menopause-related terminology definitions. (1999) (128)
Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. (2006) (121)
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women (2009) (116)
Successful pregnancy after in vitro fertilization and embryo transfer from an infertile woman to a surrogate. (1985) (96)
Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients (1999) (92)
Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women. (2009) (88)
Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis (2009) (87)
The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety (2007) (81)
Lowest Effective Transdermal 17β-Estradiol Dose for Relief of Hot Flushes in Postmenopausal Women: A Randomized Controlled Trial (2007) (81)
Human uterine cervical epithelial cells grown on permeable support--a new model for the study of differentiation. (1994) (76)
Maintenance of in vivo-like keratin expression, sex steroid responsiveness, and estrogen receptor expression in cultured human ectocervical epithelial cells. (1990) (68)
Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight. (1978) (67)
Transdermal estradiol overall safety profile. (1987) (65)
Low Dose of Transdermal Estradiol Gel for Treatment of Symptomatic Postmenopausal Women: A Randomized Controlled Trial (2007) (63)
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society (2015) (61)
Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass. (2007) (60)
Why the product labeling for low-dose vaginal estrogen should be changed (2014) (57)
Science of intracrinology in postmenopausal women (2017) (56)
The North American Menopause Society 1998 Menopause Survey. Part I: Postmenopausal women's perceptions about menopause and midlife. (1999) (56)
Comparative Trial of P1496, a New Non-steroidal Oestrogen Analogue (1973) (56)
Overview on menopause. (1987) (56)
Relief of Vasomotor Symptoms and Vaginal Atrophy With Lower Doses of Conjugated Equine Estrogens and Medroxyprogesterone Acetate (2001) (55)
Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey (2015) (54)
Quality of life (QOL) in menopause. (2007) (51)
Estrogen modulates paracellular permeability of human endothelial cells by eNOS- and iNOS-related mechanisms. (1999) (49)
Impact of hormone therapy on quality of life after menopause (2013) (46)
Menopause-related definitions (2004) (43)
A Decision Tree for the Use of Estrogen Replacement Therapy or Hormone Replacement Therapy in Postmenopausal Women: Consensus Opinion of The North American Menopause Society (2000) (42)
Retinoids, sex steroids and glucocorticoids regulate ectocervical cell envelope formation but not the level of the envelope precursor, involucrin. (1989) (41)
Preliminary experience with in vitro fertilization-surrogate gestational pregnancy. (1989) (39)
Cultured human ectocervical epithelial cell differentiation is regulated by the combined direct actions of sex steroids, glucocorticoids, and retinoids. (1990) (39)
Effect of Hysterectomy, Oophorectomy and Estrogen Therapy on Libido (1975) (37)
Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study Group. (1999) (36)
Retinoids regulate tight junctional resistance of cultured human cervical cells. (1997) (36)
Effects of Menopause and Estrogen Replacement Therapy or Hormone Replacement Therapy in Women With Diabetes Mellitus: Consensus Opinion of The North American Menopause Society (2000) (36)
Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass. (2009) (36)
Osmolar changes regulate the paracellular permeability of cultured human cervical epithelium. (1995) (35)
Effect of Premenopausal Castration and Incremental Dosages of Conjugated Equine Estrogens on Plasma Follicle‐Stimulating Hormone, Luteinizing Hormone and Estradiol (1978) (35)
Potency and hepato-cellular effects of oestrogens after oral, percutaneous, and subcutaneous administration (1982) (35)
A Risk-Benefit Appraisal of Transdermal Estradiol Therapy (1993) (35)
Role of dextran 70 in microtubal surgery. (1979) (34)
Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study (2013) (34)
Effects of estrogen in vivo on coronary vascular resistance in perfused rabbit hearts. (1995) (33)
Biphasic regulation of paracellular permeability in human cervical cells by two distinct nucleotide receptors. (1995) (31)
Brom-ergocryptine in the Treatment of Phenothiazine-Induced Galactorrhoea (1975) (30)
S-equol: a potential nonhormonal agent for menopause-related symptom relief. (2015) (29)
Definitive symptoms of post-menopause--incorporating use of vaginal parabasal cell index. (1975) (28)
The Controversial Climacteric (1982) (28)
Pieter van Keep Memorial Lecture. Menopause--a modern perspective from a controversial history. (1997) (27)
A decade post WHI, menopausal hormone therapy comes full circle – need for independent commission (2012) (27)
Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women (2004) (26)
NIH and WHI: time for a mea culpa and steps beyond. (2007) (26)
Multidisciplinary perspectives on menopause (1990) (25)
The Stages of Reproductive Aging Workshop. (2002) (25)
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong (2017) (25)
Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women (2009) (25)
Characterization of Paracellular Permeability in Cultured Human Cervical Epithelium (1994) (25)
Ovarian function, therapy-oriented definition of menopause and climacteric (1994) (24)
Pharmacy Compounding Primer for Physicians (2012) (24)
A Methodology Study to Validate a Structured Diagnostic Method Used to Diagnose Female Sexual Dysfunction and Its Subtypes in Postmenopausal Women (2005) (23)
Obstetrical implications of pregnancy in primigravidae aged 16 years or less. (1967) (23)
The true clincal features of postmenopause and oöphorectomy, and their response to oestrogen therapy. (1972) (22)
NAMS-gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy (1994) (22)
Panel Discussion 1 (1990) (22)
Letter: Effect of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women. (1973) (21)
Menopause in modern perspective : a guide to clinical practice (1980) (21)
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong (2017) (21)
A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety (2020) (20)
Monitoring skeletal response to estrogen (1989) (19)
The Menopause in Perspective From Potions to Patches (1990) (19)
The mental tonic effect of oestrogens administered to oöphorectomized females. (1972) (19)
Relief of Hot Flushes With New Plant-Derived 10-Component Synthetic Conjugated Estrogens (2004) (18)
Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms (2005) (18)
Semantics, menopause-related terminology, and the STRAW reproductive aging staging system. (2001) (18)
Effect of raloxifene on quality of life: a prospective study using the Utian Quality of Life (UQOL) Scale (2004) (17)
Critical comments. (2001) (17)
Quality of life, menopause, and hormone therapy: an update and recommendations for future research. (2018) (16)
Managing your menopause (1990) (15)
Effect of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women. (1973) (15)
Gonadotropin excretion in response to audiostimulation of human subjects. (1975) (14)
The Chinese Utian Quality of Life Scale for women around menopause: translation and psychometric testing (2012) (14)
Menopause--a proposed new functional definition. (1991) (14)
The menopause in perspective. From potions to patches. (1991) (13)
Vulvodynia A State-ofthe-Art Consensus on Definitions , Diagnosis and Management (2006) (13)
Sex hormone modulation of flow velocity in the parametrial artery of the pregnant rat. (1995) (13)
Distribution of unesterified cholesterol-containing particles in human atherosclerotic lesions. (1995) (13)
Estrogen replacement in the menopause. (1979) (12)
Effect of hysterectomy, oophorectomy and estrogen therapy on libido. (1976) (12)
Myometrial oxytocin receptors levels in the pregnant rat are higher in distal than in proximal portions of the horn and correlate with disparate oxytocin responsive myometrial contractility in these segments. (1990) (12)
A01 Pieter van Keep memorial lecture: Menopause—A modern perspective from a controversial history (1996) (11)
The Menopause and Hormonal Replacement Therapy: Facts and Controversies (1991) (11)
Kenneth William Kleinman (1946-2010) (2011) (11)
ATP decreases acutely and reversibly transport through the paracellular pathway in human cervical cells. (1994) (11)
Impact of Psychologic Factors in the Care of the Infertile Couple (1985) (10)
Effects of Estrogen on Tight Junctional Resistance in Cultured Human Umbilical Vein Endothelial Cells (1998) (10)
Response to a letter from Anderson et al (2012) (10)
The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause (2018) (10)
Oestrogen therapy and endometrial cancer. (1977) (10)
Modulation of Coronary Vascular Resistance in Female Rabbits by Estrogen and Progesterone (1998) (10)
In vitro fertilization (IVF)-surrogacy: Application of IVF to women without functional uteri (1989) (10)
Consensus statement on progestin use in postmenopausal women. (1989) (9)
[Translation, adaptation and validation of the Brazilian version of the Utian Quality of Life for evaluation of quality of life in the climacteric]. (2015) (9)
25 years of hormonal replacement therapy. (1990) (9)
Current Perspectives in the Management of the Menopausal and Postmenopausal Patient: Introduction (1990) (9)
Menopause and CME. (2004) (9)
Effects of Oophorectomy and Estrogen Therapy on Serum Cholesterol (1972) (8)
Adaptation of the Utian Quality of Life Scale to Portuguese using a community sample of Portuguese women in premenopause, perimenopause, and postmenopause (2013) (8)
Clinical and metabolic effects of the menopause and the role of replacement oestrogen therapy. (1970) (8)
TEENAGE PREGNANCY—AN INTER‐RACIAL STUDY (1970) (8)
Translation and validation of the Utian Quality of Life Scale in Serbian peri- and postmenopausal women (2015) (8)
Menopause, hormone therapy, and quality of life. (1989) (7)
Overview on menopause (1988) (7)
The Premenstrual Syndrome (1981) (7)
Adhesion prevention. (1984) (7)
An overall perspective (1978) (7)
Cholesterol, coronary heart disease and oestrogens. (1971) (6)
Menopause clinics: purpose, function and international comparisons (1982) (6)
Scientific Statement: Postmenopausal Hormone Therapy (2010) (6)
Modulation of coronary vascular resistance in female rabbits by estrogen and progesterone. (1998) (6)
An ultra-low dose (10μg) estradiol vaginal tablet improves signs and symptoms associated with vaginal atrophy (2008) (6)
Technology and techniques (1986) (6)
An historical perspective of natural and surgical menopause. (1999) (6)
Menopausal transition in Southern Europe: comparative study of women in Serbia and Portugal (2017) (6)
Application of cost-effectiveness analysis to post-menopausal estrogen therapy. (1978) (6)
Non-hormonal medication (1986) (5)
Effects of estrogen on tight junctional resistance in cultured human umbilical vein endothelial cells. (1998) (5)
Direction, misdirection and misconception in menopause research and management (1996) (5)
The place of oestriol therapy after menopause. (1980) (5)
Obstetrical risks of pregnancy and childbirth after age 35. (1988) (5)
Menopause 25th anniversary: past success and future direction. (2018) (5)
Implementation of an in vitro fertilization program (1984) (5)
The fate of the untreated menopause. (1987) (5)
Hormone Therapy and Risk of Gynecologic Cancers [2] (multiple letters) (2004) (4)
SMART-2: A PHASE III STUDY OF THE EFFICACY AND SAFETY OF BAZEDOXIFENE/CONJUGATED ESTROGENS (BZA/CE) FOR TREATMENT OF MENOPAUSAL VASOMOTOR SYMPTOMS (2009) (4)
In Vitro Fertilization — Surrogate Gestational Pregnancy (1990) (4)
Metabolic changes due to menopause and their response to oestrogen (1979) (4)
Hormones and quality of life after surgical menopause. (2006) (4)
The Menopause Manual (1978) (4)
Epidemiologic aspects of the benefits and risks of oestrogen therapy (1982) (4)
Some biochemical consequences of post-menopausal hormone replacement treatment (1982) (4)
Endometrial and ovarian safety of bazedoxifene (BZA) in the prevention of postmenopausal osteoporosis (2007) (4)
Prevention of adhesions after tubal surgery by use of dextran 70. (1980) (3)
Determining the Role of Long‐Term Hormone Therapy After Menopause in the Context of Primary Preventive Health Care for Women (1996) (3)
Beneficial effects of estrogen on cardiac stunning in female rabbits. (1999) (3)
PLASMA-ŒSTROGEN AND CLIMACTERIC SYMPTOMS (1978) (3)
Microscopic versus macroscopic tubal anastomosis in rabbit fallopian tubes. (1983) (3)
The pre-menopause (1982) (3)
Gynecologic Care of the Older Woman (2009) (3)
Introduction: What we hope to learn (1987) (3)
Summation: What we have learned (1987) (2)
Osteoporosis, oestrogens and oöphorectomy. A proposed new test of oestrogenic potency. (1975) (2)
Recent Developments in Pharmacotherapy for Vasomotor Symptoms (2012) (2)
Progesterone Attenuates the Estrogen-Induced In-crease in Coronary Flow: S-12. (1995) (2)
Problems of the untreated menopause (1984) (2)
The Symptom Complex Associated with the Menopause (1983) (2)
A Medical Perspective of Women Aged 35–45 (1982) (2)
A tribute to Isaac Schiff, MD, Editor-in-Chief (2013) (2)
The estrogen elixir: A history of hormone replacement therapy in America (2008) (2)
Oestrogens and osteoporosis. (1971) (2)
Transdermal Oestradiol (1988) (2)
The Menopause Manual: A woman’s guide to the menopause (1978) (2)
Efficacy and safety study of a new synthetic 10-component, modified release conjugated estrogens (CE) tablet for treatment of vasomotor symptoms in postmenopausal women (2002) (2)
R. Don Gambrell, Jr., MD, USAF, MC (Retired) (2007) (2)
The North American Menopause Society develops consensus opinions. (1998) (2)
Arrest of embryo development by ultrasound coupling gels. (1986) (2)
ARZOXIFENE IN POSTMENOPAUSAL WOMEN WITH NORMAL OR LOW BONE MASS (2009) (2)
Hormone therapy and risk of gynecologic cancers. (2004) (2)
Free Communication: S-5. Estrogen Increases Coronary Flow by a Nitric Oxide-Related Mechanism (1994) (1)
Adaptation and translation of the menopause-specific Utian Quality of Life (UQOL) scale to Yoruba language using middle-aged women attending a clinic in Nigeria (2019) (1)
Androgens in post-menopausal women (1982) (1)
Evaluation of Eszopiclone 3 mg in the Treatment of Insomnia Associated With the Menopausal Transition (2006) (1)
THE CAUSE OF DEATH FOLLOWING ABORTION. AN ANALYSIS OF 28 CONSECUTIVE CASES AT GROOTE SCHUUR HOSPITAL (1968) (1)
Do menopause and hormonal replacement therapy influence body cell mass and body fat mass? (1995) (1)
Amato, et al concluded that "soy isoflavone supplementation offers no benefit to quality of life in postmenopausal women". (2013) (1)
Biosynthesis and physiologic effects of estrogen and pathophysiologic effects of estrogen deficiency: A review (1990) (1)
Estrogen modulates paracellular permeability of human endothelial cells by eNOS- and iNOS-related mechanisms. (1999) (1)
Myths and realities of menopause. (1998) (1)
Introduction to ???Practical Perspectives??? (1994) (1)
Oestrogen, headache and oral contraceptives. (1974) (1)
Neuroendocrine changes in the peri-menopause (1982) (1)
Bruce Ettinger, MD (November 1938-June 2020) (2020) (1)
Development and clinical application of guidelines, consensus opinions, and position statements--the need for clinical judgment beyond the evidence. (2004) (1)
Clinical experience with transdermal estradiol in the treatment of the climacteric. (1989) (1)
Progestins in the peri-menopause (1982) (1)
New Section Enhances Journal (1999) (1)
Impact of Osteoporosis on Quality of Life and Quality of Life on Osteoporosis: Rationale and Methodology for Accurate Assessment (2006) (1)
Transdermal oestradiol. A recent advance in oestrogen therapy. (1988) (1)
Letters to the Editor: In reply (2002) (1)
Effect of conjugated oestrogen therapy on circulating luteinising hormone in oophorectomised women. (1975) (1)
Reflections on a life in menopause. (2018) (1)
Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation. (2022) (1)
Sociological aspects of mid-life (1982) (1)
Vaginal function in postmenopausal women. (1983) (1)
Ovarian management during radical hysterectomy in the premenopausal patient. (1993) (1)
Retinoids regulate tight junctional resistance of cultured human cervical cells. (1997) (1)
Prevention of postoperative adhesions (1984) (0)
Hormone replacement therapy for menopausal symptoms. (1973) (0)
Letters to the Editor. (2020) (0)
Effect of estrogen receptors (reports from the FDA, NIH, ACOG, and NAMS) and the role of testosterone and bone density. (2005) (0)
Hormone therapy and risk of gynecologic cancers. Authors' reply (2004) (0)
The social, cultural and emotional aspects (1978) (0)
Risks of hormone therapy (1978) (0)
Introduction (1994) (0)
The incidence and significance of clinical foetal distress in labour. (1971) (0)
The Role of Platelets in Prevention of Coronary Heart Disease in Postmenopausal Women—A Review (1994) (0)
Letter to the editor in response to "omissions, biases, and nondisclosed conflicts of interest: Is there a hidden agenda in the NAMS position statement?" (2005) (0)
Sign Out: Our 40-year ride on the hormone therapy rollercoaster (2007) (0)
Managing menopause in the posthormone therapy era (2005) (0)
The frequently prescribed sex hormones (1978) (0)
The North American Menopause Society at 25 years: celebrating our history and looking to the future. (2014) (0)
To the Editor. (2020) (0)
The peri-menopause at the cellular level (1982) (0)
Postmenopausal osteoporosis. (1979) (0)
Estrogen Increases Transendothelial Cation Selectivity: A Novel Vasculoprotective Mechanism: S-5. (1996) (0)
Doses, Duration, and Starting Age for HRT Treatment: The American Viewpoint (1999) (0)
Panel Discussion 2 (1990) (0)
Gonadal function in the ageing male (1982) (0)
Sexual activity after the menopause (1978) (0)
A Cumulative Vasomotor Index for Analysis of Hot Flush Severity in a 12‐Week Clinical Trial (2003) (0)
Septic abortion and septic shock. (1973) (0)
Chapter-50 Commentaries on Indian Menopause Society Guidelines, on Menopause and Osteoporosis (2015) (0)
Preface (1990) (0)
Magnets for Patients With Heel Pain (2017) (0)
A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life (2023) (0)
A New Scholarly Journal on Menopause (1994) (0)
Hairspray as an inexpensive fixative for Papanicolaou smears. (1972) (0)
Executive summary? All about validating scales and stages: Reply of the authors (2002) (0)
Panel Discussion 3 (1990) (0)
Historical development of menopausal issues. Have we delivered what we promised? (2019) (0)
Preliminary experience with in vitro fertilization‐surrogate gestational pregnancy (1990) (0)
Foetal distress--is the paediatrician necessary? (1969) (0)
Oestrogens in oophorectomized women. (1971) (0)
To the Editor. (2017) (0)
Psycho-sexual aspects of mid-life (1982) (0)
Life after menopause (1978) (0)
Female structure and function (1978) (0)
Commentary on guidelines on postmenopausal osteoporosis - Indian Menopause Society (2013) (0)
What are the key issues women face when ending hormone replacement therapy? (2003) (0)
Oestrogen therapy and menopausal flushing. (Letter to the editor) (1976) (0)
S-2.: Effects of Estrogen on Cardiac Stunning in Female Rabbits (1997) (0)
Hormones, Cognition and Dementia: Epilogue (2009) (0)
Therapieüberwachung durch Knochendichtemessung bei Östrogensubstitutionstherapie (1990) (0)
North American Menopause Society: Treasuring the Past – Shaping the Future (2006) (0)
Beneficial Effects of Estrogen on Cardiac Stunning in Female Rabbits (1999) (0)
Estradiol valerate/dienogest. Viewpoints (2002) (0)
True effects of menopause and role of replacement hormones (1978) (0)
Effect of Estrogen Receptors (Reports from the FDA, NIH, ACOG, and NAMS) and the Role of Testosterone and Bone Density (2005) (0)
POSTMENOPAUSAL OSTEOPOROSIS (1979) (0)
The use of isoflavinoids in menopausal health (2012) (0)
ŒSTROGEN THERAPY AND MENOPAUSAL FLUSHING (1976) (0)
Menopause, hormones and ageing. (1973) (0)
Surrogate gestational carriers (1989) (0)
Changing populations and vital statistics (1978) (0)
Fernand Labrie, OC, OQ, MD, PhD, FRCPC, FRSC, CAHS (June 28, 1937–January 16, 2019) (2019) (0)
Cholesterol-Containing Particles in Human Atherosclerotic Lesions (2007) (0)
Editorial: Nancy Fugate Woods, PhD, RN, FAAN: 1999-2000 NAMS President (1999) (0)
ŒSTROGEN THERAPY AND " ETERNAL YOUTH " (1975) (0)
Human chorionic gonadotrophin in the treatment of threatened and recurrent abortion. A preliminary reappraisal. (1974) (0)
Lila E. Nachtigall, MD: 2000???2001 NAMS President (2000) (0)
Tubal and Peritoneal Factors in Infertility (1985) (0)
Panel Discussion 4 (1990) (0)
Dental obstetrics. (1975) (0)
Teenage pregnancy--an intr-racial study. (1970) (0)
Surgery as a cause early menopause (1978) (0)
Practicalities of the visit to the physician (1978) (0)

This paper list is powered by the following services:

Other Resources About Wulf H. Utian

en.wikipedia.org

What Schools Are Affiliated With Wulf H. Utian?

Wulf H. Utian is affiliated with the following schools:

Image Attributions

Image Source for Wulf H. Utian